Jan 12 (Reuters) - Revvity said on Monday it expects its 2025 adjusted profit per share to exceed its forecast of $4.90 to $5, as the medical equipment maker benefits from renewed demand for contract research and diagnostics services.
The company's shares were up nearly 6% in extended trading.
Pharmaceutical companies have ramped up drug development in the U.S. amid evolving trade policies under President Donald Trump.
Revvity said it expects to report fourth-quarter revenue of around $772 million, above Wall Street estimates of $760.3 million, according to data compiled by LSEG.
It also expects annual revenue to grow 4% to $2.86 billion, above estimates of $2.84 billion.
The company will report its fourth-quarter and full year 2025 results on February 2.
(Reporting by Puyaan Singh in Bengaluru; Editing by Leroy Leo)
LATEST POSTS
- 1
This Unique National Park In Canada Is Famous For Its Otherworldly Limestone Monoliths - 2Ukrainian drones hit all three Baltic States − did Russia redirect them?
- 3Firefighters rescue two Israelis trapped in vehicles on flooded roads in West Bank
- 4Washington state experiences historic flooding as Skagit River hits record high level. See flooding maps, highway closures and forecasts.
- 5What to expect from the planets in 2026 — key dates and sky events
- I'm an 83-year-old yoga instructor. I'm not your typical grandma — I still work to feel fulfilled and supplement my Social Security.
- Haifa refinery said hit in latest Iranian missile barrage
- 5 Wellbeing Applications Assist You With remaining Fit
- The Iconic, Instantly Recognizable Plastic Chair That's Known All Around The World
- Building an Individual Brand: Illustrations from Forces to be reckoned with
- King Charles III says he is reducing cancer treatment schedule in 2026
- NASA just launched Artemis 2. What happens today could make or break the moon mission
- As cases of a rare, deadly infection rise, doctors worry fewer teens will get vaccinated
- NASA’s Pandora telescope will study stars in detail to learn about the exoplanets orbiting them
